See more : TLD3 Entertainment Group, Inc. (TLDE) Income Statement Analysis – Financial Results
Complete financial analysis of Ajanta Pharma Limited (AJANTPHARM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ajanta Pharma Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Twin Ridge Capital Acquisition Corp. (TRCA-WT) Income Statement Analysis – Financial Results
- Neil Industries Limited (NEIL.BO) Income Statement Analysis – Financial Results
- Xiamen Hexing Packaging Printing Co., Ltd. (002228.SZ) Income Statement Analysis – Financial Results
- Shenzhen XFH Technology Co.,Ltd (300890.SZ) Income Statement Analysis – Financial Results
- Les Toques Blanches du Monde Société Anonyme (MLTBM.PA) Income Statement Analysis – Financial Results
Ajanta Pharma Limited (AJANTPHARM.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ajantapharma.com
About Ajanta Pharma Limited
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as antimalarial, cardiology, ophthalmology, dermatology, pain management, gastroenterology, antihistamine, respiratory, diabetes areas. It also provides tablets, capsules, powder, liquid, jelly, ointments, sterile eye drops, active pharma ingredient. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.09B | 37.43B | 32.84B | 28.47B | 25.62B | 20.16B | 20.60B | 19.16B | 17.08B | 14.55B | 11.81B | 9.22B | 6.77B | 5.05B | 4.08B | 3.49B | 3.09B | 2.58B | 2.30B | 1.99B |
| Cost of Revenue | 11.15B | 10.50B | 8.87B | 6.82B | 6.90B | 4.24B | 4.72B | 4.71B | 4.50B | 3.87B | 3.60B | 3.12B | 2.30B | 1.73B | 1.46B | 1.27B | 1.40B | 1.40B | 1.22B | 1.03B |
| Gross Profit | 30.93B | 26.92B | 23.97B | 21.65B | 18.72B | 15.93B | 15.88B | 14.46B | 12.58B | 10.69B | 8.21B | 6.10B | 4.47B | 3.32B | 2.62B | 2.22B | 1.69B | 1.18B | 1.08B | 951.33M |
| Gross Profit Ratio | 73.50% | 71.93% | 73.00% | 76.03% | 73.06% | 79.00% | 77.10% | 75.44% | 73.65% | 73.44% | 69.52% | 66.17% | 66.05% | 65.75% | 64.30% | 63.63% | 54.69% | 45.72% | 46.91% | 47.91% |
| Research & Development | 2.08B | 2.37B | 2.04B | 1.39B | 1.64B | 1.76B | 1.86B | 1.50B | 1.06B | 700.70M | 590.40M | 412.90M | 0.00 | 248.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.30B | 710.70M | 545.90M | 384.00M | 283.10M | 208.40M | 300.40M | 263.20M | 214.20M | 159.30M | 133.60M | 116.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 2.53B | 2.27B | 2.98B | 2.38B | 3.04B | 2.41B | 2.27B | 2.08B | 1.92B | 1.93B | 1.61B | 1.34B | 0.00 | 0.00 | 487.56M | 0.00 | 0.00 | 0.00 | 198.45M | 200.53M |
| SG&A | 9.12B | 2.98B | 3.52B | 2.77B | 3.33B | 2.62B | 2.57B | 2.35B | 2.14B | 2.09B | 1.74B | 1.45B | 0.00 | 0.00 | 487.56M | 0.00 | 0.00 | 0.00 | 198.45M | 200.53M |
| Other Expenses | 0.00 | 986.40M | 152.90M | 56.00M | 68.70M | 11.50M | 5.10M | 39.70M | 7.00M | 2.90M | 8.90M | 3.00M | 3.32B | 2.33B | 1.56B | 1.69B | 1.24B | 862.11M | 623.68M | 554.71M |
| Operating Expenses | 11.20B | 20.40B | 15.86B | 12.72B | 12.61B | 10.90B | 9.81B | 7.78B | 7.15B | 6.15B | 4.96B | 4.20B | 3.32B | 2.58B | 2.05B | 1.69B | 1.24B | 862.11M | 822.13M | 755.24M |
| Cost & Expenses | 22.41B | 30.90B | 24.72B | 19.55B | 19.51B | 15.13B | 14.52B | 12.49B | 11.65B | 10.01B | 8.56B | 7.32B | 5.62B | 4.30B | 3.51B | 2.96B | 2.64B | 2.26B | 2.04B | 1.79B |
| Interest Income | 277.10M | 84.60M | 146.50M | 35.10M | 10.60M | 19.10M | 9.50M | 23.90M | 35.20M | 111.40M | 99.20M | 18.60M | 11.33M | 0.00 | 5.00M | 2.77M | 0.00 | 0.00 | 858.00K | 205.00K |
| Interest Expense | 72.10M | 58.40M | 102.00M | 82.70M | 119.10M | 11.60M | 4.10M | 12.40M | 25.00M | 36.90M | 65.10M | 133.90M | 241.33M | 178.21M | 201.60M | 235.52M | 161.44M | 123.77M | 120.49M | 101.46M |
| Depreciation & Amortization | 1.35B | 1.30B | 1.25B | 1.16B | 952.20M | 720.80M | 595.90M | 612.10M | 450.60M | 516.40M | 438.80M | 341.70M | 318.69M | 247.49M | 207.34M | 141.99M | 78.74M | 87.45M | 89.51M | 92.24M |
| EBITDA | 12.57B | 8.81B | 10.44B | 10.24B | 7.71B | 5.88B | 6.83B | 7.11B | 6.06B | 5.14B | 3.82B | 2.30B | 1.47B | 991.36M | 796.54M | 667.12M | 528.98M | 404.94M | 350.00M | 287.68M |
| EBITDA Ratio | 29.86% | 23.56% | 31.16% | 35.90% | 30.92% | 28.88% | 32.99% | 37.62% | 35.19% | 35.65% | 32.19% | 24.33% | 21.69% | 19.64% | 19.52% | 19.34% | 17.10% | 15.69% | 15.34% | 14.49% |
| Operating Income | 19.68B | 6.62B | 8.08B | 8.90B | 5.88B | 4.95B | 6.07B | 6.67B | 5.43B | 4.54B | 3.25B | 1.90B | 1.15B | 743.88M | 571.59M | 533.66M | 450.24M | 317.49M | 255.47M | 196.09M |
| Operating Income Ratio | 46.75% | 17.68% | 24.60% | 31.27% | 22.94% | 24.53% | 29.48% | 34.82% | 31.78% | 31.18% | 27.51% | 20.64% | 16.99% | 14.73% | 14.02% | 15.28% | 14.55% | 12.31% | 11.12% | 9.87% |
| Total Other Income/Expenses | -8.54B | 341.80M | -6.86B | 364.60M | 535.00M | -5.03B | -4.85B | 407.50M | 29.20M | -3.47B | -218.20M | -135.20M | -191.22M | -178.21M | -183.99M | -221.55M | -161.44M | -123.77M | -112.95M | -102.10M |
| Income Before Tax | 11.14B | 7.45B | 9.09B | 9.00B | 6.64B | 5.14B | 6.23B | 6.48B | 5.47B | 4.56B | 3.30B | 1.77B | 909.58M | 565.66M | 387.61M | 298.14M | 288.79M | 193.73M | 142.52M | 93.99M |
| Income Before Tax Ratio | 26.47% | 19.91% | 27.69% | 31.62% | 25.92% | 25.50% | 30.23% | 33.82% | 32.06% | 31.34% | 27.93% | 19.18% | 13.43% | 11.20% | 9.51% | 8.53% | 9.33% | 7.51% | 6.20% | 4.73% |
| Income Tax Expense | 2.98B | 1.57B | 1.97B | 2.46B | 1.96B | 1.27B | 1.54B | 1.41B | 1.46B | 1.46B | 959.70M | 646.80M | 136.93M | 58.54M | 47.57M | 43.83M | 68.50M | 46.67M | 18.35M | -5.48M |
| Net Income | 8.16B | 5.88B | 7.13B | 6.54B | 4.68B | 3.87B | 4.69B | 5.07B | 4.01B | 3.10B | 2.34B | 1.12B | 772.66M | 507.13M | 340.04M | 254.31M | 218.81M | 146.61M | 123.46M | 98.49M |
| Net Income Ratio | 19.39% | 15.71% | 21.70% | 22.97% | 18.26% | 19.19% | 22.75% | 26.45% | 23.51% | 21.30% | 19.80% | 12.16% | 11.41% | 10.04% | 8.34% | 7.28% | 7.07% | 5.68% | 5.37% | 4.96% |
| EPS | 64.82 | 45.89 | 54.97 | 50.06 | 35.73 | 29.32 | 35.50 | 38.39 | 31.49 | 23.49 | 17.75 | 8.51 | 5.86 | 3.85 | 2.58 | 1.93 | 1.66 | 1.11 | 0.94 | 0.75 |
| EPS Diluted | 64.77 | 45.89 | 54.96 | 50.06 | 35.73 | 29.31 | 35.50 | 38.39 | 31.49 | 23.47 | 17.71 | 8.49 | 5.85 | 3.85 | 2.58 | 1.93 | 1.66 | 1.11 | 0.94 | 0.75 |
| Weighted Avg Shares Out | 125.92M | 128.12M | 129.66M | 130.62M | 130.89M | 132.00M | 132.00M | 132.01M | 131.99M | 131.91M | 131.81M | 131.75M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M |
| Weighted Avg Shares Out (Dil) | 126.01M | 128.12M | 129.66M | 130.62M | 130.90M | 132.02M | 132.03M | 132.04M | 132.00M | 132.04M | 132.04M | 132.06M | 132.03M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M | 131.72M |
Source: https://incomestatements.info
Category: Stock Reports